SA

Spectral AI, Inc.

MDAI·NASDAQ

$2.01

+0.75%
HealthcareMedical - Devices

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.

At a Glance

Live Snapshot
Market Cap$63.97M
EPS-0.2900
P/E Ratio-6.93
Earnings Date08/11/2026

mdai

Additional Paid-In Capital

Last Annual Value

50.03M

3-Year CAGR

28%

5-Year CAGR

%

10-Year CAGR

%

SA

Spectral AI, Inc. Competitors Analysis of Additional Paid-In Capital

MDAI · NASDAQ
CompanyAdditional Paid-In Capital
CAGR 3Y
CAGR 5Y
CAGR 10Y
50.03M
17.2%17.2%N/A 
127.20M
11.5%33.4%N/A
950.81M
4.2%3.9%N/A
46.09M
0.5%0.9%7.2%
244.43M
5.5%6.7%N/A
339.85M
110.9%N/AN/A
119.14M
17.7%16.4%N/A
573.27M
2.9%3.5%N/A
164.22M
11.3%89.5%18.3%
1.47B
2.8%5.9%10.7%
TELA logo
TELA Bio, Inc.
NASDAQ:TELA
403.74M
5.9%10.1%N/A
SA

Spectral AI, Inc. Fair Value Envelope

MDAI · NASDAQ

Our analysis suggests that MDAI has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $2.01, this represents a potential HIDDEN relative to our calculated worth for Spectral AI, Inc..

Intrinsic Value
Current Price: $2.01